Literature DB >> 27163647

Preoperative Myocardial Injury as a Predictor of Mortality in Emergency General Surgery: An Analysis Using the American College of Surgeons NSQIP Database.

Asha M Zimmerman1, Jayson Marwaha1, Hector Nunez1, David Harrington1, Daithi Heffernan1, Sean Monaghan1, Charles Adams1, Andrew Stephen2.   

Abstract

BACKGROUND: Recent studies have linked postoperative serum troponin elevation to mortality in a range of different clinical scenarios. To date, there has been no investigation into the significance of preoperative troponin elevation in emergency general surgery (EGS) patients. We define this as preoperative myocardial injury (PMI). We hypothesize that PMI seen in EGS patients may predict postoperative morbidity and mortality. STUDY
DESIGN: Using the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) database, we performed a retrospective review of all EGS cases between 2008 and 2014. Patients with preoperative troponin I drawn were compared.
RESULTS: There were 464 EGS patients who had troponin I measurements preoperatively. Eighty-two (18%) had preoperative troponin elevations. Patients with PMI were more likely to have the following preoperative physiologic derangements: acute renal failure (18% vs 4%; p = 0.002) and septic shock (40% vs 13%; p < 0.001). Patient comorbidities associated with PMI included congestive heart failure (13% vs 3%; p = 0.007), dialysis dependence (16% vs 3%; p = 0.002), and American Society of Anesthesiologists (ASA) class ≥ 4 (52% vs 29%; p < 0.001). Compared with controls, patients with PMI had higher rates of postoperative events (77% vs 52%; p < 0.001) and mortality (34% vs 13%; p = 0.009). Univariate analysis showed that patients with PMI had an increased risk of postoperative events (odds ratio [OR] 3.02; 95% CI 1.74 to 5.25) and mortality (OR 3.53; 95% CI 1.66 to 7.47). Multivariate analysis revealed preoperative troponin I elevation was an independent predictor of mortality (OR 3.03; 95% CI 1.19 to 7.72, p = 0.020).
CONCLUSIONS: Emergency general surgery patients with PMI are at increased risk for postoperative events and death. Preoperative myocardial injury is an independent predictor of mortality and has prognostic utility that can prepare surgical teams for adverse events so that they can be recognized, evaluated, and treated earlier.
Copyright © 2016 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27163647     DOI: 10.1016/j.jamcollsurg.2016.04.043

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  4 in total

1.  Prognostic performance of preoperative cardiac troponin and perioperative changes in cardiac troponin for the prediction of major adverse cardiac events and mortality in noncardiac surgery: A systematic review and meta-analysis.

Authors:  Caroline A S Humble; Stephen Huang; Ib Jammer; Jonas Björk; Michelle S Chew
Journal:  PLoS One       Date:  2019-04-22       Impact factor: 3.240

2.  Perioperative myocardial injury in revascularized coronary patients who undergo noncardiac surgery.

Authors:  Seung-Hwa Lee; Myung Soo Park; Young Bin Song; Jungchan Park; Jaeyoun Kim; Sangmin Maria Lee; Young Tak Lee
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

3.  Comparison of pre- and postoperative myocardial injuries on mortality after non-cardiac surgery: a retrospective analysis using an inverse probability weighting adjustment.

Authors:  Seung-Hwa Lee; Jungchan Park; Jong-Hwan Lee; Jeong Jin Min; Kwan Young Hong; Hyojin Cho; Keumhee Carriere; Joonghyun Ahn
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

4.  Preoperative high-sensitivity troponin I and B-type natriuretic peptide, alone and in combination, for risk stratification of mortality after liver transplantation.

Authors:  Young-Jin Moon; Hye-Mee Kwon; Kyeo-Woon Jung; Kyoung-Sun Kim; Won-Jung Shin; In-Gu Jun; Jun-Gol Song; Gyu-Sam Hwang
Journal:  Korean J Anesthesiol       Date:  2020-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.